Page 3 - கொரியா அடிப்படை அறிவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Abstract Despite the remarkable advances in therapeutics for rheumatoid arthritis (RA), a large number of patients still lack effective countermeasures. Recently, the reprogramming of macrophages to an immunoregulatory phenotype has emerged as a promising therapeutic strategy for RA. Here, we report metabolically engineered exosomes that have been surface-modified for the targeted reprogramming of macrophages. Qualified exosomes were readily harvested from metabolically engineered stem cells by tangential flow filtration at a high yield while maintaining their innate immunomodulatory components. When systemically administered into mice with collagen-induced arthritis, these exosomes effectively accumulated in the inflamed joints, inducing a cascade of anti-inflammatory events via macrophage phenotype regulation. The level of therapeutic efficacy obtained with bare exosomes was achievable with the engineered exosomes of 10 times less dose. On the basis of the boosted nature to reprog

United statesSoult ukpyolsiSouth koreaCastillay leópRepublic of koreaTakara bioExosomes exosLeica biosystemsBioanalyzer santa claraAnalyte elisarrayExos mscKorea basic science institute national research facilitiesYounglin coScience research programsKorea basic science instituteAgilent technologies